By harnessing cutting-edge diagnostic technologies and fostering collaboration, the GM Advanced Diagnostics Accelerator is transforming healthcare, improving patient outcomes, and driving economic growth.
Background
The Greater Manchester Advanced Diagnostics Accelerator is a pioneering initiative designed to bridge the gap between research and clinical implementation of advanced diagnostic technologies. With a focus on major global morbidities such as liver, heart, and lung diseases, this initiative aims to enhance population health and reduce the burden on healthcare services.
Funded with £7.7 million through the Innovation Accelerator programme, the project brings together academia, industry, NHS stakeholders, and local communities. By leveraging Manchester’s expertise in Bioinformatics, Genomics, and AI, the programme is developing innovative pathways for early disease detection and targeted care, leading to improved health outcomes and economic stimulation.
Inspiration
The GM Advanced Diagnostics Accelerator is driven by a mission to address healthcare inequalities, improve early disease detection, and create innovative care pathways. The programme is committed to:
- Engaging patients and communities in healthcare advancements.
- Enhancing diagnostic efficiency through AI and cutting-edge technologies.
- Supporting underserved communities with targeted healthcare solutions.
- Through active community engagement and collaboration, the programme has involved over 1,200 patients in research and treatment activities, ensuring that new healthcare innovations are patient-centred and effective.
Innovation and Impact
- 29 high-value jobs created, with 50+ jobs sustained.
- One new spinout company established (KAVARNEY LTD).
- £2.7 million in co-investment secured.
- Engagement with 800+ patients engaged via treatment or research activities, 400 of which are from underserved communities.
Using a network of partners, this programme is focused on developing innovative pathways for early disease detection and targeted care, ultimately enhancing health outcomes and stimulating economic growth in areas such as:
- Treatment of liver disease in patients much earlier.
- Development of a new approach for finding more people at risk of heart failure, focusing on communities most in need.
- Lung cancer screening through new digital approaches.
- Chest pain – Developing diagnostic tools for paramedics before patients reach hospital.
- Community diagnostics – Improve the identification of people at risk of lung disease, heart disease, and other cardiometabolic conditions, focused on underserved communities.
- Remote Spirometry for the diagnosis of COPD.
Conclusion
The Greater Manchester Advanced Diagnostics Accelerator is leading the way in healthcare innovation by integrating advanced diagnostic technologies, improving early detection, and ensuring equitable access to healthcare. Through strategic collaboration and investment, the initiative is making a tangible impact on patient outcomes, healthcare efficiency, and economic growth, positioning Greater Manchester as a leader in medical diagnostics and innovation.